Personalized total neoadjuvant therapy versus chemotherapy during the ‘wait period’ versus standard chemoradiotherapy for locally advanced rectal cancer
Sign Up to like & getrecommendations! Published in 2022 at "ANZ Journal of Surgery"
DOI: 10.1111/ans.18229
Abstract: This study aimed to compare current treatment response rates with personalized Total Neoadjuvant Therapy (pTNT), against extended chemotherapy in the ‘wait period’ (xCRT) and standard chemoradiotherapy (sCRT) with adjuvant chemotherapy for rectal cancer. read more here.
Keywords: neoadjuvant therapy; standard chemoradiotherapy; total neoadjuvant; personalized total ... See more keywords